RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Edward C. Bell to Ductus Arteriosus, Patent

This is a "connection" page, showing publications Edward C. Bell has written about Ductus Arteriosus, Patent.
Connection Strength

2.637
  1. McNamara PJ, Chock VY, Rahde-Bischoff A, Gabrio J, Johnson KJ, Harmon HM, Montoya-Williams D, Colaizy TT, Katheria AC, Ines F, Sorrells K, Battersby C, Levy PT, Rysavy MA, Bhombal S, Laughon MM, Carper B, Hintz SR, Das A, Bell EF. Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trial. BMJ Open. 2025 Aug 26; 15(8):e105018.
    View in: PubMed
    Score: 0.949
  2. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2014; (12):CD000503.
    View in: PubMed
    Score: 0.451
  3. Kaluarachchi DC, Rysavy MA, Do BT, Chock VY, Laughon MM, Backes CH, Colaizy TT, Bell EF, McNamara PJ. Changes in Patent Ductus Arteriosus Management and Outcomes in Infants Born at 26-28?Weeks' Gestation. J Pediatr. 2025 Apr; 279:114456.
    View in: PubMed
    Score: 0.227
  4. Kaluarachchi DC, Rysavy MA, Carper BA, Chock VY, Laughon MM, Backes CH, Colaizy TT, Bell EF, McNamara PJ. Secular Trends in Patent Ductus Arteriosus Management in Infants Born Preterm in the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 2024 Mar; 266:113877.
    View in: PubMed
    Score: 0.211
  5. Chawla S, Natarajan G, Laptook AR, Chowdhury D, Bell EF, Ambalavanan N, Carlo WA, Gantz M, Das A, Tapia JL, Harmon HM, Shankaran S. Model for severe intracranial hemorrhage and role of early indomethacin in extreme preterm infants. Pediatr Res. 2022 12; 92(6):1648-1656.
    View in: PubMed
    Score: 0.187
  6. Bischoff AR, Giesinger RE, Bell EF, McNamara PJ. Precision medicine in neonatal hemodynamics: need for prioritization of mechanism of illness and defining population of interest. J Perinatol. 2020 09; 40(9):1446-1449.
    View in: PubMed
    Score: 0.167
  7. Dagle JM, Ryckman KK, Spracklen CN, Momany AM, Cotten CM, Levy J, Page GP, Bell EF, Carlo WA, Shankaran S, Goldberg RN, Ehrenkranz RA, Tyson JE, Stoll BJ, Murray JC. Genetic variants associated with patent ductus arteriosus in extremely preterm infants. J Perinatol. 2019 03; 39(3):401-408.
    View in: PubMed
    Score: 0.149
  8. Boghossian NS, Do BT, Bell EF, Dagle JM, Brumbaugh JE, Stoll BJ, Vohr BR, Das A, Shankaran S, Sanchez PJ, Wyckoff MH, Bethany Ball M. Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants. Early Hum Dev. 2017 10; 113:10-17.
    View in: PubMed
    Score: 0.135
  9. Spanos WC, Brookes JT, Smith MC, Burkhart HM, Bell EF, Smith RJ. Unilateral vocal fold paralysis in premature infants after ligation of patent ductus arteriosus: vascular clip versus suture ligature. Ann Otol Rhinol Laryngol. 2009 Oct; 118(10):750-3.
    View in: PubMed
    Score: 0.079
  10. Bell EF, Strauss RG, Widness JA, Mahoney LT, Mock DM, Seward VJ, Cress GA, Johnson KJ, Kromer IJ, Zimmerman MB. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics. 2005 Jun; 115(6):1685-91.
    View in: PubMed
    Score: 0.058
  11. Wadhawan R, Oh W, Vohr BR, Saha S, Das A, Bell EF, Laptook A, Shankaran S, Stoll BJ, Walsh MC, Higgins R. Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18-22 months corrected age. Arch Dis Child Fetal Neonatal Ed. 2013 Mar; 98(2):F127-32.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support